OVID ovidrx.com Kompaniyaning sof daromadi

Ovid Therapeutics (OVID) kompaniyasining rasmiy ramzlari

Ovid Therapeutics Inc. (OVID) ilmiy xatarlarni kamaytirgan holda, og'ir miya patologiyalariga chalingan bemorlar uchun terapiya vositalarini ishlab chiqishga e'tibor qaratadi. Noyob molekulalarga bo'lgan yuqori talab emitentga sezilarli narx belgilash imkoniyatini beradi. Kompaniya tadqiqotlarni sinalgan laboratoriyalarga autsorsing qilish orqali xarajatlarni optimallashtirishga erishmoqda. Kompaniyaning sof balansi foyda dinamikasini namoyish etadi, bunda -0.03 metrik qiymati joriy moliyaviy natijani aks ettiradi.

OVID: Ovid Therapeutics Inc. Sof foyda 04.07.2022 - 01.11.2026

ovidrx.com (OVID) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Ovid Therapeutics|OVID - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati OVID|OVID - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans bo'yicha xususiy kapital ma'lumotlari:
Bitta aksiya uchun sof aktivlar Ovid Therapeutics|OVID - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi ovidrx.com|OVID - Kompaniyaning umumiy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Ovid Therapeutics Inc.|OVID - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Ovid Therapeutics|OVID - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati OVID|OVID - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Ovid Therapeutics|Shoshilinch likvidlik ovidrx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
OVID - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Ovid Rx - OVID
Ovid Therapeutics Inc brendining mahsuloti

Yuqori sifatli emitentlarni tanlash biznesning haqiqiy qiymatini belgilovchi sof foyda tendentsiyalari orqali operatsion samaradorlik tahliliga asoslanadi. Ovid Therapeutics Inc. (OVID) uchun ushbu naqd foyda barcha xarajatlar chegirib tashlangan yakuniy moliyaviy natijani o'lchaydi, bu esa Ovid Therapeutics Inc. (OVID) hamkorlardan oraliq to'lovlarni monitoring qilish va klinik bosqichlardan o'tishda juda muhim bo'lib, investorga kapitalning qadrsizlanish xavfini o'z vaqtida aniqlash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniyaning sof daromadi regencellbioscience.com RGC|Sof daromad AXSM (Axsome Therapeutics, Inc.)|Kompaniyaning sof foydasi ACAD (ACADIA Pharma)|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Sof moliyaviy natija Viking Therapeutics Corp (VKTX)|Supernus Pharmaceuticals - Sof foyda|CPRX (catalystpharma.com) - Kompaniya foydasi|DNLI (Denali Therapeutics Inc.) - Sof daromad|Harmony Biosciences Inc - Yakuniy foyda|Sof daromad BHVN|AMLX (Amylyx Corp) - Soliqlar to‘langandan keyingi foyda|Sof foyda TRVI|PRAX (praxismedicines.com) - Yakuniy foyda|Sof foyda AVXL (Anavex Life Sciences Corp.)|CeriBell Inc (CBLL) - Kompaniyaning sof daromadi|PRTA - Kompaniyaning sof foydasi|Yakuniy foyda ALEC (Alector, Inc.)|ANNX: Sof foyda|Omeros (OMER) - Sof foyda|Kompaniyaning sof foydasi Neurogene|AC Immune S.A. - Soliqdan keyingi foyda|Sof foyda VYGR|NMRA - Kompaniyaning sof daromadi|Scilex Holding Company - Sof daromad|Sof foyda tevogen.com TVGN|ACOG: Sof daromad|cogrx.com - Soliqlar to‘langandan keyingi foyda|IKT: Sof foyda|SAVA - Sof moliyaviy natija|ASRT (Assertio Holdings) - Sof foyda|Sof daromad Coya (COYA)|Kompaniyaning sof foydasi Vistagen Therapeutics (VTGN)|Sof moliyaviy natija Acumen Pharmaceuticals Inc.|CervoMed Inc - Sof daromad|Yakuniy foyda ATHE|Clene Nanomedicine - Sof foyda|Sof moliyaviy natija PepGen Inc. PEPG|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning sof foydasi|Kompaniya foydasi RLMD|ANVS (Annovis Bio Corp) - Sof foyda|Sof daromad Grace Tx (GRCE)|Sof daromad AIFF (Firefly Neuroscience, Inc)|Sof moliyaviy natija anewmeds.com|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Kompaniyaning sof daromadi|MTVA: Sof daromad|NRXS: Kompaniyaning sof foydasi|HSDT: Sof foyda|PASG - Sof moliyaviy natija|NEUP (Neuphoria Therapeutics, Inc.) - Sof foyda|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Kompaniyaning sof foydasi Athira (ATHA)|Addex - Kompaniya foydasi|Sof foyda ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|PTIX: Sof daromad|KTTA - Sof foyda|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Avenue Therapeutics Inc - Yakuniy foyda|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniyaning sof daromadi caratherapeutics.com CARA|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|ELYM - Kompaniyaning sof daromadi|Intra-Cellular Therapies, Inc. - Sof daromad|Longboard - Kompaniyaning sof foydasi|Marinus Pharmaceuticals - Sof foyda|Sof moliyaviy natija nkgenbiotech.com NKGN|NRBO: Sof foyda|Kompaniya foydasi SAGE|Sof daromad SNPX|TRVN: Yakuniy foyda|Sof daromad VIGL (Vigil Neuroscience)|Soliqlar to‘langandan keyingi foyda WENA|Sof foyda CERE (Cerevel Therapeutics, Inc.)